B8FK — Biofrontera AG Cashflow Statement
0.000.00%
Last trade - 00:00- €16.47m
- €13.54m
- €21.67m
- 32
- 65
- 63
- 52
Annual cashflow statement for Biofrontera AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -12.7 | 35.7 | -43.2 | -2.13 | -6.72 |
| Depreciation | |||||
| Non-Cash Items | 6.3 | -12.6 | 44 | 6.57 | 3.63 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.78 | 4.05 | -5.39 | -7.14 | -0.294 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.85 | 30.4 | -3.9 | -1.91 | -2.54 |
| Capital Expenditures | -0.774 | -0.629 | -0.981 | -0.912 | -0.21 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 3.65 | -41.6 | 0 | — | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | 2.87 | -42.3 | -0.981 | -0.912 | -0.21 |
| Financing Cash Flow Items | -1.19 | -6.86 | -0.262 | -0.012 | -0.086 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 5.95 | 2.18 | 4.34 | -0.479 | 2.79 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.43 | -9.64 | -0.532 | -3.3 | 0.044 |